NICE guidelines recommend specific GLP-1 receptor agonists as part of a comprehensive approach to diabetes management (NG28) and, in specific circumstances, for weight management in individuals with obesity or overweight with comorbidities (TA875 for semaglutide, TA664 for liraglutide)
Nhm i tng ph hp dng GLP-1 thng l ngi tha cn, bo ph, c ch s m bng cao hoc ang gp tnh trng khng insulin, tin tiu ng, tiu ng type 2
Stavrakis, A
Crosstalk between the redox signalling and the detoxification: GSTs under redox control
European Journal of Biochemistry 224, 203213 (1994)
Thats a good thingbecause despite all the changes in this landscape, the demand for effective, affordable medications that help with weight loss and improve overall health isnt going anywhere